Brandinium

Trademark search for:

NUBU PHARMACEUTICALS

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2019-03-14 — Application filed
  • 2019-06-06 — Sn assigned for sect 66a appl from ib
  • 2019-06-12 — Application filed
  • 2019-06-12 — Assigned to examiner
  • 2019-06-18 — Application filed
  • 2019-07-24 — Final disposition recorded
  • 2019-07-25 — Office action issued
  • 2019-08-19 — Office action issued
  • 2019-10-03 — Final disposition recorded
  • 2019-10-04 — Office action issued
  • 2019-10-17 — Office action issued
  • 2019-10-17 — Office action issued
  • 2019-11-01 — Office action issued
  • 2020-02-27 — Office action issued
  • 2020-02-27 — Correspondence received in law office
  • 2020-02-28 — Teas/email correspondence entered
  • 2020-03-15 — Examiners amendment -written
  • 2020-03-15 — Examiners amendment e-mailed
  • 2020-03-15 — Notification of examiners amendment e-mailed
  • 2020-03-15 — Examiner's amendment entered
  • 2020-03-15 — Approved for pub - principal register
  • 2020-04-01 — Notification of notice of publication e-mailed
  • 2020-04-21 — Published for opposition
  • 2020-04-21 — Official gazette publication confirmation e-mailed
  • 2020-07-07 — Registered-principal register
  • 2020-10-07 — Final disposition recorded
  • 2020-10-29 — Final disposition recorded
  • 2020-10-29 — Final disposition recorded
  • 2020-11-21 — Final disposition recorded
  • 2022-11-11 — Cancellation instituted no. 999999
  • 2023-07-17 — Petition for expungement received 
  • 2023-07-17 — Notice of submission of e/r petition to registrant's email
  • 2023-08-24 — Assigned to rex/exp proceeding staff
  • 2023-09-05 — Proceeding instituted - expungement
  • 2024-03-01 — Office action issued
  • 2024-06-03 — Expungement ex parte appeal received at ttab
  • 2024-06-25 — Jurisdiction restored to examining attorney
  • 2024-06-25 — Ex parte appeal-instituted
  • 2024-10-24 — Exparte appeal dismissed - failure to file brief
  • 2024-11-26 — Exparte appeal terminated
  • 2024-12-11 — Notice of termination issued - expungement
  • 2024-12-11 — Cancellation under 16a full
  • 2024-12-11 — Final status recorded
  • 2025-03-13 — Cancellation denied no. 999999
  • 2025-03-13 — Cancellation terminated no. 999999

Owner Information

MW PHARMA LIMITED
NZ
MW PHARMA LIMITED
NZ
MW PHARMA LIMITED
NZ

Correspondent

WILLIAM C. WRIGHT EPSTEIN DRANGEL LLP
60 EAST 42ND STREET, SUITE 1250
NEW YORK, NY 10165
UNITED STATES

Filing Details

Filing Date:
2019-03-14
Status Date:
2024-12-11
Category:
Pharmaceuticals
Filing Year:
2019

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.